Global lung cancer surgery market size to touch USD 7 billion by 2027

The latest research literature report on ‘global lung cancer market’ deeply explores all critical factors like shares, size, growth drivers, obstacles, and opportunities in accordance with the past, present, and future outlook.

Selbyville, Delaware, July 13, 2021 (GLOBE NEWSWIRE) -- As per the informed views of expert analysts and seasoned forecasters, global lung cancer surgery market, valued USD 5.4 billion in 2020, is projected to register 3.8% CAGR over 2021-2027 and subsequently amass a valuation of USD 7 billion by the end of the stipulated timeframe.

Taking the analysis further, a detailed country-level investigation of the key regions, namely Asia Pacific, Europe, North America, and Latin America is presented in the research document. Moreover, the market is also studied from the perspective of surgical devices and surgical procedures. The research piece also renders a 360-degree outlook of the competitive arena with respect to leading companies, emerging contenders, and new players in this domain.

Growing prevalence of lung cancer across the globe is augmenting the industry growth. In fact, the World Health Organization claims that cancer was the world's second-leading cause of death in 2018. Further, over 10 million fatalities from cancer and 19.3 million new cases were recorded in 2020.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3930302/

Elevated risk factor among the increasing tobacco smoking individuals and booming elderly population base are also enhancing the industry growth. Moreover, technological advancements in cancer therapy, rising inclination towards early cancer detection and treatment, along with positive outlook of the reimbursement scenario are adding considerable momentum to the industry expansion.

On the contrary, high costs associated with diagnosis and surgeries will negatively impact the industry growth in the upcoming years.

Geographical analysis overview:

Asia Pacific, North America, Latin America, and Europe are the top contributors to the overall lung cancer surgery market expansion. Among these regions, North America currently captures majority industry share and will likely record strong gains in the ensuing years. This can be ascribed to increasing technological innovations, and rising frequency of lung cancer in the region.

Asia Pacific market is touted to showcase a remarkable growth rate over the assessment period, attributable to growing tobacco consumption and heightened focus on early diagnosis & treatment of cancer.

Competitive landscape review:

Accuray Inc., AngioDynamics Inc., Ethicon US LLC, Intuitive Surgical Inc., Olympus Corp., Teleflex Inc., Ackermann Instrumente GmbH, Richard Wolf GmbH, Siemens Healthineers AG, and Scanlan International Inc. are the top contenders influencing global lung cancer surgery industry dynamics. These players are increasingly focusing on research & development, partnerships, and investment to improve their market stance.